Tenax Therapeutics is trading at $2.09, up 5.56%, with no verified September 8 company announcement directly explaining the after-hours move.
- Closed at $1.98 on September 8, 2026.
- Scheduled to present at the Cantor Global Healthcare Conference on September 9, 2026, at 8:35 a.m. EDT; this may be a near-term attention point, but causation is unconfirmed.
- Broader market conditions were mixed rather than clearly supportive.